Investor Relations

PureTech Health is building the biopharma company of the future with an advanced, clinical stage pipeline of new medicines targeting serious chronic diseases caused by dysfunctions in the brain, gut & immune systems.

For Investor Relations inquiries, please contact PureTech Health’s Investor Relations team at IR@puretechhealth.com.

For more information, please use the links to the right.